Work

Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.9550

Authors: Michael A. Postow, Susan Jane Knox, Debra Goldman, Katherine Panageas, Darragh Halpenny, Danielle McCabe, Mary J. Macri, Paul Schwarzenberger, Toni Ricciardi, Aileen Ryan, Ralph Rudolph Venhaus, Christopher Andrew Barker

Institutions: Memorial Sloan Kettering Cancer Center, Stanford Medicine, Stanford University, Ludwig Cancer Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891216815

Cites:

Cited by:

Related to: 10